[HTML][HTML] Pharmacotherapy of anxiety disorders: current and emerging treatment options

A Garakani, JW Murrough, RC Freire, RP Thom… - Frontiers in …, 2020 - frontiersin.org
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised …

G Andrews, C Bell, P Boyce, C Gale… - Australian & New …, 2018 - journals.sagepub.com
Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale

JSW Hong, LZ Atkinson, N Al-Juffali, A Awad… - Molecular …, 2022 - nature.com
The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated
calcium channels. Initially licensed for pain and seizures, they have become widely …

Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art

GJG Asmundson, J Katz - Depression and anxiety, 2009 - Wiley Online Library
The purpose of this article is to describe the current state‐of‐the‐art regarding the co‐
occurrence of the anxiety disorders and chronic pain. First, we describe the core …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

The pharmacologic treatment of anxiety disorders: a review of progress

LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

MJ Field, PJ Cox, E Stott, H Melrose, J Offord… - Proceedings of the …, 2006 - pnas.org
Neuropathic pain is a debilitating condition affecting millions of people around the world and
is defined as pain that follows a lesion or dysfunction of the nervous system. This type of …

Anxiety in patients with epilepsy: systematic review and suggestions for clinical management

S Beyenburg, AJ Mitchell, D Schmidt, CE Elger… - Epilepsy & Behavior, 2005 - Elsevier
Up to 50 or 60% of patients with chronic epilepsy have various mood disorders including
depression and anxiety. Whereas the relationship between epilepsy and depression has …

Management of bipolar disorder during pregnancy and the postpartum period

KA Yonkers, KL Wisner, Z Stowe… - American Journal of …, 2004 - psychiatryonline.org
OBJECTIVE: Bipolar disorder affects 0.5%–1.5% of individuals in the United States. The
typical age at onset is late adolescence or early adulthood, placing women at risk for …